Status:
UNKNOWN
Comparison of Upper and Lower Limb Maximal Exercise Capacities and Muscle Oxygenation in Patients With ILD
Lead Sponsor:
Gazi University
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
18-75 years
Brief Summary
Interstitial lung diseases (ILD) are a complex group of diseases that cause significant morbidity and mortality, develop diffuse lung parenchyma and alveolar inflammation, as well as interstitial fibr...
Detailed Description
As a result of the chronic inflammatory process of the disease, structural and mechanical pulmonary disorders develop, which are cited as the causes of deterioration in cardiopulmonary functions. In t...
Eligibility Criteria
Inclusion
- patients between the ages of 18-75 with interstitial lung disease
Exclusion
- acute infection during the study
- have an orthopedic or neurological disease that will affect their exercise capacity
- acute exacerbation or any infection
- have contraindications to the exercise test
- an acute respiratory infection
- had Coronavirus-19 (COVID-19) disease in the last 3 months
- have undergone different treatments other than standard medical treatment
Key Trial Info
Start Date :
November 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06141603
Start Date
November 25 2023
End Date
December 30 2024
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit
Ankara, Çankaya, Turkey (Türkiye), 06490